$MNDY (+3,22%)
$TSN (-2,03%)
$OXY (+1,28%)
$WULF (-2,59%)
$PLUG (+0,5%)
$RKLB (+8,65%)
$CRWV (+1,68%)
$9984 (+1,03%)
$IOS (+1,91%)
$MUV2 (-1,26%)
$SE (+2,3%)
$NBIS (+8,2%)
$RGTI (+1,41%)
$$BYND (+5,26%)
$OKLO
$IFX (+5,34%)
$EOAN (+1,02%)
$TME (-4,44%)
$VBK (+4,63%)
$HDD (-0,86%)
$ONON (+0,36%)
$JMIA (+1,89%)
$MRX (+1,35%)
$HTG (+0%)
$DTE (+0,13%)
$R3NK (-1,68%)
$HLAG (+4,6%)
$JD (+0,1%)
$700 (+0,5%)
$DIS (+0,72%)
$ENEL (+1,38%)
$AMAT (+4,29%)
$NU (+0,32%)
$ALV (-0,03%)
$SREN (-1,47%)
$BAVA (+2,48%)

Bavarian Nordic
Price
Discussão sobre BAVA
Postos
15Quarterly figures 10.11-14.11.25
Was die europäischen Aktien am Morgen bewegt 🇪🇺👇🏼
Upside ⬆️
- Evotec $EVT (+5,45%) 20.0% (Halozyme confirms proposal to combine with Evotec for €11.00/shr in €2.0B All-Cash deal)
- TT Electronics $TTG (+3,75%) +38.5% (rejects offers to be acquired)
- Generali $G (-0,43%) +4.5% (9-month results)
- Aegon $AGN +2.5% (Q3 trading update)
- Aviva $AV. (+0,31%) +0.5% (HSBC raised to buy)
- Touax $TOX +1.0% (earnings)
Downside ⬇️
- ASML Holding $ASML (+1,48%) -2.5% (Applied Materials results)
- Sanofi $SAN (+1,64%) -3.5%, Astrazeneca $AZN (+4,52%) -2.5% (Trump taps vaccine skeptic RFK Jr. to head HHS)
- Bavarian Nordic $BAVA (+2,48%) -17.5% (Q3 results, heavily misses estimates; Trump taps vaccine skeptic RFK Jr. to head HHS)
- Nexans $NEX (-4,32%) -3.5% (Bpifrance confirmed selling 2.5% stake in Nexans)
- Givaudan $GIVN (+1,32%) -1.5% (Barclays cuts to underweight; accident)
- NKT $NKT (-0,99%) -1.5% (Danske Bank raised to buy)
Bavarian Nordic $BAVA (+2,48%), Figures missed, market reacts clearly, How low will it go? Is now a good time to get in?! https://de.marketscreener.com/kurs/aktie/BAVARIAN-NORDIC-A-S-1412846/news/ebitda-Ergebnis-von-Bavarian-Nordic-deutlich-schlechter-als-erwartet-48373231/
$BAVA (+2,48%) small position speculative run, because Bavarian Nordic the manufacturer for the #impfung the #affenpocken
#mpox in Europe.
Bavarian Nordic and BioNTech are two interesting companies in the field of Mpox vaccines. Bavarian Nordic offers the only licensed vaccine (MVA-BN) and is expanding globally to meet the growing demand. BioNTech, on the other hand, is developing an mRNA vaccine that could ensure flexible and rapid production thanks to its technology. $BAVA (+2,48%)
$BNTX (+1,57%)
Bavarian Nordic has proven products, while BioNTech could convince through innovation. Both companies offer a lot of potential, but which approach is more successful in the long term? What do you think?
I think the monkeypox issue is more of a flash in the pan.
$APDN
$GOVX Shares rise as rally for monkeypox treatment begins 👀
Shares up over 100% in the last few days
not to forget $BAVA (+2,48%)
Mpox virus boosts Bavarian Nordic shares. $BAVA (+2,48%)
$DK0061268711 Similar to Biontech $BNTX (+1,57%) and co with Covid19.
I bought 7 shares today.
The declaration of a global health emergency due to the Mpox virus by the World Health Organization (WHO) gave Bavarian Nordic a boost. The shares of the Danish biotechnology company rose by up to 17 percent and reached 261 kroner, the highest level in almost two years. Bavarian Nordic produces a vaccine against Mpox and announced on Tuesday that the EU agency for crisis preparedness and response HERA had placed an order for vaccine doses to be delivered to Africa. The company also received 156.8 million dollars from the US government to expand its vaccine production.

Did anyone else hear the report on this stock on "alles auf Aktien" this morning?
I was convinced by the report and the subsequent research and bought a first small tranche of 2x11 shares.
I know people who have worked there 😅
How do you currently estimate $NVAX (+2,73%) and $VLA (+9,41%) rate?
I am currently down about 76% on Novavax and about 71% on Valneva.
From $BAVA (+2,48%) this week with a little plus. Now I have the question, wait for a turnaround in the other two or rather sell now to avoid going even further into the red?
I know, no one has a crystal ball but the exchange is always interesting. ☺️
Títulos em alta
Principais criadores desta semana

